Crizotinib
Catalog No.: BA4BC7
CAS.RN：877399-52-5
Molecular Formula: C21H22Cl2FN5O
Molecular Weight: 450.34 g/mol
Purity: NLT 98%
Intermediates of Crizotinib
| Catalog No. | Product Name | CAS |
|---|---|---|
| BA4BC7 | Crizotinib API | 877399-52-5 |
| BK24BM | 5-bromo-3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]pyridin-2-amine | 877399-00-3 |
| BK554D | tert-Butyl 4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]piperidine-1-carboxylate | 877399-74-1 |
| BK05Y9 | 1-Piperidinecarboxylic acid, 4-(4-iodo-1H-pyrazol-1-yl)-,1,1-dimethylethyl ester | 877399-73-0 |
| BK176T | (R)-tert-butyl 4-(4-(6-amino-5-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridine -3-yl)-1H-pyrazol-1-yl)piperidine-1-carboxylate | 877399-51-4 |
| BK7QY5 | (S)-1-(2,6-dichloro-3-fluorophenyl)ethanol | 877397-65-4 |
Products are offered for research, development, or industrial use only.
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
